Announcements Trials
Browse Landscape

Phase

Phase 2 64Phase 3 52Phase 1 15Phase 1/2 14Phase 4 6Phase NA 5Phase 2/3 5Phase EARLY_PHASE1 3

Status

Completed 3Recruiting 2Active not recruiting 1

Sponsor Class

OTHER 5INDUSTRY 1

Study Type

Interventional 6

Sponsor

Cancer Type

Breast 4

Conditions

Breast Neoplasms 4Leiomyoma 1Carcinoma, Ductal 1

Interventions

Dexamethasone 13Saline Solution 8Bupivacaine 8Bevacizumab 8Tobacco Use Cessation Devices 7Specimen Handling 7Nivolumab 7Magnetic Resonance Spectroscopy 7Lenalidomide 7Fluorouracil 7pembrolizumab 6Rituximab 6Prednisone 6Letrozole 6Carboplatin 6Propofol 5Human Papillomavirus Recombinant Vaccine nonavalent 5trametinib 4lenvatinib 4dabrafenib 4cabozantinib 4anlotinib 4Trastuzumab 4Tamoxifen 4Standard of Care 4Sodium Chloride 4Ropivacaine 4Paclitaxel 4Immune Checkpoint Inhibitors 4Esomeprazole 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 4 × Letrozole × 1 year × Clear all
NCT06143631 2026-05-20

PLUM

University of California, San Francisco

Phase 4 Recruiting
140 enrolled

Leiomyoma

NCT01127295 2026-04-14

PHACS

Institut Claudius Regaud

Phase 4 Completed
2,000 enrolled
Breast

Breast Neoplasms

NCT01553903 2026-04-14

OXYTAM

Institut Claudius Regaud

Phase 4 Completed
29 enrolled
Breast

Breast Neoplasms

NCT01612871 2026-04-14

MIRHO

Institut Claudius Regaud

Phase 4 Completed
39 enrolled
Breast

Breast Neoplasms

NCT05161195 2026-04-02

Roll-over Study to Allow Continued Access to Ribociclib

Novartis

Phase 4 Active not recruiting
134 enrolled
Breast

Breast Neoplasms

NCT05183828 2026-01-26

Effect of HSD3B1 (1245C) Gene Mutation on Treatment of Stage I-III Breast Cancer

University of Washington

Phase 4 Recruiting
68 enrolled

Carcinoma, Ductal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡